Bonus Share News: This company, which has grown in profits and earnings, will give bonus for the first time, also gifting a dividend of Rs 7.

News Topical, Digital Desk : Bonus Share News: Diagnostics company Dr. Lal PathLabs Ltd. has released its September quarter (Q2FY25) results. The company's filing stated that its profits, revenue, and operating performance showed steady improvement across all three fronts.

The company's net profit increased from ₹129 crore to ₹151 crore year-over-year, registering growth of approximately 17%. Revenue also increased from ₹660 crore to ₹731 crore.

EBITDA increased from ₹202 crore to ₹224.3 crore. However, the company's EBITDA margin remained stable at 31% during the quarter, indicating strong operational efficiency. Diagnostic chain Dr. Lal PathLabs Ltd. made significant announcements for its shareholders with its September quarter (Q2FY26) results. The company not only announced a dividend of ₹7 per share for the second time, but also decided to issue 1:1 bonus shares for the first time. 

Dividend Announcement The Board of Dr. Lal PathLabs has declared a second interim dividend (70%) of ₹7 per share of ₹10 face value. The record date for this dividend is November 7, 2025, and payment will be made within the next 30 days. Previously, the Company declared a first interim dividend of ₹6 per share in July 2025 and a final dividend of ₹6 for March 2025. 

Bonus Shares in a 1:1 Ratio As a bonus gift to shareholders, the Company has decided to issue bonus shares in a 1:1 ratio, meaning one additional share will be awarded for every 1 share held. These bonus shares will be issued from the Securities Premium Account. A total of 83.7 million bonus shares will be issued, with a total value of approximately ₹83.77 crore. Credit or dispatch of the bonus shares will be completed by December 30, 2025. 

Increase in Authorized Capital The company has also proposed to increase its authorized share capital from ₹107.96 crore to ₹200 crore to fund a bonus issue and future expansion. 

The Employee Benefit Scheme Board has also introduced a new 'Dr. Lal PathLabs Employee Restricted Stock Unit Plan 2025 (RSU 2025)' for employees, under which options equivalent to 5,27,403 shares will be granted to employees. 

Market Position Dr. Lal PathLabs shares are currently trading at around ₹3,090.6. The promoter stake in the company is 53.21% and it has over 1.05 lakh retail shareholders. This is the first time the company is offering bonus shares to its investors. Until now, the company was only distributing dividends.

Read More: The company that bought JP Associates suffered a massive 44% loss, and how much dividend will the company pay this time?